Dksh Technology LIMITED

Dksh Technology LIMITED, a Thailand-based for-profit company, provides laboratory equipment maintenance, spare parts procurement, and preventive maintenance services to the Department of the Army Medical Command, Defense Health Agency, and Department of the Navy as a prime contractor exclusively — the vendor operates without federal subcontract activity and competes on full-and-open purchase orders and blanket purchase agreement call orders with no set-aside designations.

Dksh Technology's federal footprint is concentrated on support for the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok, Thailand. The vendor holds a single-award Blanket Purchase Agreement (BPA 19GE5023A0001) with the Department of the Army Medical Command running through December 2025, against which three task orders totaling $73 thousand have been issued for preventive maintenance on specialized laboratory instruments including nitrogen generators and mass spectrometers. Recent representative prime awards include a $28.7 thousand firm fixed-price purchase order from the Defense Health Agency awarded January 22, 2026, for acquisition of a lab pusher spare part supporting AFRIMS operations (completion March 20, 2026); a $28.9 thousand purchase order from the Defense Health Agency awarded July 25, 2025, for laboratory equipment spare parts; and a $24.2 thousand BPA call from the Department of the Army Medical Command awarded December 15, 2022, for preventive maintenance services on nitrogen generators and mass spectrometers (completion December 14, 2023).

Customer concentration is split between the Defense Health Agency (2 awards, $58 thousand combined potential value) and the Department of the Army Medical Command (3 awards, $48 thousand combined potential value), with a single $47 thousand Department of the Navy purchase order rounding out the portfolio. All seven awards in the source data are classified under medical laboratory or equipment maintenance NAICS and PSC categories. Activity has remained modest and episodic — two awards in 2022, two in 2023, and one each in 2024, 2025, and 2026 — with a combined potential value of $177 thousand fully obligated. The vendor's footprint is entirely overseas, supporting U.S. military medical research infrastructure in Thailand with no domestic prime or sub work documented in the source.